RNA expression-based risk stratification of stage III cutaneous melanoma

被引：0
|
作者：
Kim, Donghyun [1 ]
Yu, Yeonhwa [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21551
引用
收藏
页数：1
相关论文
共 50 条
  • [41] FLT3 and NPM1 mRNA expression-based risk stratification of de novo acute Myeloid Leukemia
    Kim, Donghyun
    Sutamtewagul, Grerk
    Yu, Yeonhwa
    LEUKEMIA RESEARCH REPORTS, 2025, 23
  • [42] Expression of the embryological morphogen Nodal in stage III/IV melanoma
    Hooijkaas, Anna I.
    Gadiot, Jules
    van Boven, Hester
    Blank, Christian
    MELANOMA RESEARCH, 2011, 21 (06) : 491 - 501
  • [43] FLT3 and NPM1 mRNA Expression-Based Risk Stratification of De Novo Acute Myeloid Leukemia
    Kim, Donghyun
    Sutamtewagul, Grerk
    Yu, Yeonhwa
    BLOOD, 2024, 144 : 6132 - 6133
  • [44] Evaluation of the risk of relapse of patients with stage III cutaneous melanoma at event-free survival time points.
    Weppler, Alison M.
    Lee, Derrick G.
    van Niekerk, Dirk
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma
    Van Laar, Ryan
    Latif, Babak
    King, Sam
    Love, Christopher
    Taubenheim, Nadine
    Kalansooriya, Esha
    Wang, Wandi
    Saad, Mirette
    Winship, Ingrid
    Azzi, Anthony
    Lilleyman, Alister
    Landgren, Tony
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) : 292 - 301
  • [46] ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy
    Hussain, Zahra
    Moncrieff, Marc
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1820 - 1821
  • [47] ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy
    Zahra Hussain
    Marc Moncrieff
    Annals of Surgical Oncology, 2023, 30 (3) : 1820 - 1821
  • [48] Adjuvant Immunotherapy in Stage II Melanoma-Further Risk Stratification is Needed
    Rashdan, Hannah
    Adamson, Adewole
    Semenov, Yevgeniy R.
    JAMA DERMATOLOGY, 2024, 160 (04) : 385 - 386
  • [49] Anticipating the Clinical Use of Prognostic Gene Expression-Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving?
    Sveen, Anita
    Nesbakken, Arild
    Agesen, Trude H.
    Guren, Marianne G.
    Tveit, Kjell M.
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6669 - 6677
  • [50] Disease-modifying factors in hereditary angioedema: an RNA expression-based screening
    Alberto López-Lera
    Fátima Sánchez Cabo
    Sofía Garrido
    Ana Dopazo
    Margarita López-Trascasa
    Orphanet Journal of Rare Diseases, 8
12345